Key statistics
On Thursday, Amylyx Pharmaceuticals Inc (AMLX:NSQ) closed at 5.19, 229.52% above the 52 week low of 1.58 set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.23 |
---|---|
High | 5.42 |
Low | 4.98 |
Bid | 5.15 |
Offer | 5.42 |
Previous close | 5.23 |
Average volume | 1.97m |
---|---|
Shares outstanding | 68.55m |
Free float | 54.27m |
P/E (TTM) | -- |
Market cap | 358.51m USD |
EPS (TTM) | -3.82 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
- Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
- Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
- Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024
- Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
More ▼